HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keytam S Awad Selected Research

heminordihydroguaiaretic acid (Mal.4)

7/2007A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keytam S Awad Research Topics

Disease

2Pulmonary Arterial Hypertension
01/2021 - 01/2018
1Heart Failure
01/2018
1Pulmonary Hypertension
01/2018
1Inflammation (Inflammations)
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1Complementation Group B Xeroderma Pigmentosum
01/2018
1Vascular Remodeling
09/2016
1Type 2 Diabetes Mellitus (MODY)
08/2015
1Neoplasms (Cancer)
07/2007
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2005
1Mitochondrial Diseases (Mitochondrial Disease)
01/2005

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2007
1Interferon Type IIBA
01/2021
1InterferonsIBA
01/2021
1Caveolin 1IBA
01/2021
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2018
1MonocrotalineIBA
01/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2018
1Transcription Factor TFIIHIBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Spironolactone (Aldactone)FDA LinkGeneric
01/2018
1LigandsIBA
08/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2015
1LignansIBA
07/2007
1heminordihydroguaiaretic acid (Mal.4)IBA
07/2007
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2005
1Superoxide Dismutase-1IBA
01/2005
1Apoptosis Regulatory ProteinsIBA
01/2005
1Alanine (L-Alanine)FDA Link
01/2005
1Caspase 3 (Caspase-3)IBA
01/2005

Therapy/Procedure

2Therapeutics
01/2021 - 09/2016